4//SEC Filing
Brown Douglas Matthew 4
Accession 0001077183-22-000039
CIK 0001077183other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 7:57 PM ET
Size
14.9 KB
Accession
0001077183-22-000039
Insider Transaction Report
Form 4
Brown Douglas Matthew
Chief Strategy Officer
Transactions
- Tax Payment
Common Stock
2022-03-02−867→ 76,379 total - Award
Common Stock
2022-03-01+35,030→ 77,246 total - Award
Stock Option (Right to Buy)
2022-03-01+85,519→ 85,519 totalExercise: $21.41Exp: 2029-03-01→ Common Stock (85,519 underlying)
Holdings
- 45,017
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (45,017 underlying) - 26,378
Stock Option (Right to Buy)
Exercise: $53.17Exp: 2028-03-02→ Common Stock (26,378 underlying)
Footnotes (5)
- [F1]On March 1, 2022, Mr. Brown was granted 35,030 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
- [F2]Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2022 vesting of restricted stock.
- [F3]On March 2, 2020, Mr. Brown was granted 45,017 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F4]On March 2, 2021, Mr. Brown was granted 26,378 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 1, 2022, Mr. Brown was granted 85,519 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001849414
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 7:57 PM ET
- Size
- 14.9 KB